Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19

NCT04655586 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: rNAPc2
DRUG: Heparin

Sponsor

ARCA Biopharma, Inc.

Collaborators

[object Object]